Ajanta Pharma Limited (NSE:AJANTPHARM)
India · Delayed Price · Currency is INR 3,051.00
+16.00 (0.53%)
May 11, 2026, 3:30 PM IST
Ajanta Pharma Market Cap
Ajanta Pharma has a market cap or net worth of 379.03 billion as of May 11, 2026. Its market cap has increased by 12.63% in one year.
Market Cap
379.03B
Enterprise Value
374.99B
Revenue
56.25B
Ranking
n/a
PE Ratio
35.91
Stock Price
3,051.00
Market Cap Chart
Since April 1, 2002, Ajanta Pharma's market cap has increased from 565.80M to 379.03B, an increase of 66,891.39%. That is a compound annual growth rate of 30.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 379.03B | 9.61% |
| Dec 31, 2025 | 345.80B | -5.57% |
| Dec 31, 2024 | 366.20B | 39.58% |
| Dec 29, 2023 | 262.36B | 68.96% |
| Dec 30, 2022 | 155.28B | -19.73% |
| Dec 31, 2021 | 193.46B | 36.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alkem Laboratories | 667.83B |
| Glenmark Pharmaceuticals | 667.80B |
| Laurus Labs | 663.11B |
| Ipca Laboratories | 393.90B |
| Gland Pharma | 313.76B |
| Emcure Pharmaceuticals | 311.50B |
| Wockhardt | 261.04B |
| Piramal Pharma | 238.81B |